Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Delta variant wave. by Rima Moghnieh (679199)

Subjects:

Parameter estimates from the final models for <i>M</i>. <i>mercenaria</i> & <i>M</i>. <i>arenaria</i> mortality. by Teagan McMahon (20108036)

Table 1_NSAID use may decrease serum Klotho levels.docx by Jingchao Yan (14079168)

“…Subgroup analyses did not reveal any statistically significant interactions.</p>Conclusion<p>Contrary to previous speculations, the use of NSAIDs is associated with a decrease in serum Klotho levels.…”

Spatial econometric model estimation results. by Zijie Li (776536)

Flowchart of the study population. by Gábor Szaló (22615130)

“…Among those 803 individuals who did not take antihypertensive medication, there was a significant association in linear regression between increase in PSS-10 and decrease in C2 (B: −0.2, 95% CI: −0.4- −0.02; p = 0.03) that was lost after adjustment for physical activity (B: −0.16, 95% CI: −0.35–0.03; p = 0.1). …”

Characteristics of study population. by Gábor Szaló (22615130)

“…Among those 803 individuals who did not take antihypertensive medication, there was a significant association in linear regression between increase in PSS-10 and decrease in C2 (B: −0.2, 95% CI: −0.4- −0.02; p = 0.03) that was lost after adjustment for physical activity (B: −0.16, 95% CI: −0.35–0.03; p = 0.1). …”

Results of weighted arcsine-transformed linear regression of the age-and sex-standardised epilepsy prevalence (y) and age- and sex-standardised anti-Ov16 seroprevalence (x<sub>1</s... by Luís-Jorge Amaral (16406704)

Subjects:

Linear mixed model results, fixed effects for time points, group, time points x group and univariate effects in the neck-specific exercise with internet support (NSEIT) group and t... by Anneli Peolsson (7867601)

<i>Estimated metabolic rates among the simulation workflows</i>. by Israel Luis (13916706)

Changes in AL (A) and SE (B) according to the treatment time estimation curve in patients given 0.125% atropine. by Zi-Rong Chen (9227618)

Subjects:

Recruitment flow diagram of the current study. by Somayeh Momenyan (10111603)

“…Phase 1 EQ-VAS decreases were associated with female sex, lower somatic symptom, fewer comorbidities, lack of expectation for a fast recovery, higher ISS, higher injury pain, neck, spine/back or lower extremity injuries. …”

summary of the confidence intervals. by Yohannis Derbew Molla (16471771)

Subjects:

pooled proportions along with the total sample size (n) for each cause of traumatic brain injury. by Yohannis Derbew Molla (16471771)

Subjects:

PRISMA flowchart of the study selection process. by Yohannis Derbew Molla (16471771)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the mixed Delta and Omicron variant wave. by Rima Moghnieh (679199)

Subjects:

The DALYs, deaths, and their estimated annual percentage changes of ischemic heart disease attributable to high systolic blood pressure from 1990 to 2021. by Zhenhua Zhuang (11192745)

Estimating RSA Variability across Treatment, Time, and Condition. by Hikari Otsuka (18605246)

Summary of the expected results with corresponding hypotheses. by Marcel F. Hinss (14675457)

Subjects:

The Ishihara test for colourblindness [41] encompasses stimuli that can determine the degree and type of colourblindness a person has. by Marcel F. Hinss (14675457)

Subjects:

The demographics questionnaire includes questions about age, education, gender and employment. by Marcel F. Hinss (14675457)

Subjects: